insulin lispro

This medicine is authorised for use in the European Union.


Liprolog is a range of insulin medicines used to treat patients who have diabetes and need insulin to keep their blood glucose (sugar) level controlled, including patients whose diabetes has just been diagnosed.
Liprolog medicines contain the active substance insulin lispro on its own or combined with protamine to make it longer acting:

  • Liprolog (100 units/ml): standard-strength insulin lispro (fast-acting);
  • Liprolog (200 units/ml): high-strength insulin lispro (fast-acting);
  • Liprolog Mix25 (100 units/ml): 25% insulin lispro (fast-acting) and 75% insulin lispro protamine (longer-acting);
  • Liprolog Mix50 (100 units/ml): 50% insulin lispro (fast-acting) and 50% insulin lispro protamine (longer-acting).

This EPAR was last updated on 30/01/2023

Authorisation details

Product details
Agency product number
Active substance
insulin lispro
International non-proprietary name (INN) or common name
insulin lispro
Therapeutic area (MeSH)
Diabetes Mellitus
Anatomical therapeutic chemical (ATC) code
  • A10AB04
  • A10AD04
Publication details
Marketing-authorisation holder
Eli Lilly Nederland B.V.
Date of issue of marketing authorisation valid throughout the European Union
Contact address
Eli Lilly Nederland BV
Grootslag 1-5,
NL-3991 RA Houten
The Netherlands

Product information

26/01/2023 Liprolog - EMEA/H/C/000393 - N/0157

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilisation of diabetes mellitus.

Assessment history

How useful was this page?

Add your rating
2 ratings